Sopharma AD (WSE:SPH)
Poland flag Poland · Delayed Price · Currency is PLN
12.75
-0.25 (-1.92%)
Aug 13, 2025, 6:56 PM CET

Sopharma AD Company Description

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices, such as gauzes, compresses, and dressing.

The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; concentrates for hemodialysis; and prescription medicines, and OTC and veterinary medical products.

In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services.

Further, it is involved in trading of pharmaceuticals; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services.

Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities.

Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Sopharma AD
CountryBulgaria
Founded1933
IndustryMedical Distribution
SectorHealthcare
Employees5,599
CEOOgnian Donev

Contact Details

Address:
16, Iliensko Shousse St.
Sofia, 1220
Bulgaria
Phone359 28 13 42 00
Websitesopharmagroup.com

Stock Details

Ticker SymbolSPH
ExchangeWarsaw Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyBGN
ISIN NumberBG11SOSOBT18
SIC Code2834

Key Executives

NamePosition
Dr. Ognian Ivanov Donev M.D., Ph.D.Chairman, Chief Executive Officer and MD
Boris Anchev BorisovChief Financial Officer and Financial Director
Iordanka Nikolova PetkovaChief Accountant
Pelagia Stefanova ViatchevaDirector of Investor Relations
Alexandar YotovHead of Legal Department
E. KrastevaDirector of Advertising and Corporate Communications
Lyudmila BondzhovaHead of Reporting Department
E. MihailovaHead of Production Division
S. KatzarovaHead of Regulatory Affairs Bulgaria and Third Markets Division
M. KotzevaHead of Drug Safety Department